SIRP1α targeted chimeric proteins and uses thereof
US12084497B2 · kind B2 · utility
0Cited by
20References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 8, 2019 |
| Grant date | Sep 10, 2024 |
| Priority date | — |
| Expiry date | Jun 6, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/33
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in part, to agents that bind SIRP1α and their use as diagnostic and therapeutic agents. The present invention further relates to pharmaceutical compositions comprising the SIRP1α targeting moiety and their use in the treatment of various diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.